The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study
David P. Faxon, MD*,*,
Raymond J. Gibbons, MD ,
Nicolas A. F. Chronos, MD ,
Paul A. Gurbel, MD ,
Florence Sheehan, MD, PhD|| HALT-MI Investigators
* Los Angeles County Medical Center and the University of Southern California School of Medicine, Los Angeles, California, USA
Mayo Clinic, Rochester, Minnesota, USA
Emory University Hospital, Atlanta, Georgia, USA
Sinai Hospital, Center for Thrombosis Research, Baltimore, Maryland, USA
|| University of Washington, Seattle, Washington, USA

View larger version (28K):
[in a new window]
|
Figure 1 (A and B) HALT-MI infarct size by single-photon emission computed tomography, imputed values and observed data. LV = left ventricular.
|
|
|